Tabituximab (ONC-005) is a humanized monoclonal antibody targeting frizzled class receptor 10 (FZD10) with antitumor activity for the study of immune system diseases.
Purity:
96.40%
CAS Number:
[1644134-10-0]
Target:
Wnt/beta-catenin
* VAT and and shipping costs not included. Errors and price changes excepted